Arbutus Biopharma Corporation announced that Tram Tran, MD has notified the company of her intention to resign from the company's Board of Directors, effective February 26, 2023. Dr. Tran will be transitioning into public service commencing February 27, 2023, that will preclude her participation on the Arbutus and other pharmaceutical and biotechnology Boards. Dr. Tran joined the Arbutus Board of Directors in November 2021 and served as a member of the Executive Compensation and Human Resources Committee.

During her tenure, she has contributed her extensive virology and clinical development expertise to provide guidance and valuable insights to drive the company's hepatitis B and COVID-19 pipeline.